{"entity":{"id":"nct05768529","kind":"trial","name":"Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","aka":[],"tldr":"A phase 1/2 trial of U16 in non-Hodgkin lymphoma, run by Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, now recruiting.","summary":"Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma is a phase 1/2 interventional study registered as NCT05768529 by Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, with 100 participants planned, started 2023-03-28 and due to reach its primary completion in 2024-12-31. Interventions recorded: U16.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05768529","url":"https://clinicaltrials.gov/study/NCT05768529"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["unicar-therapy"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05768529","phase":"1/2","setting":"A Single-arm, Open and Multicenter Phase I/II Clinical Study to Evaluate the Safety and Efficacy of U16 Injection in the Treatment of Refractory/Recurrent B-cell Non-Hodgkin's Lymphoma (r/r B-NHL)","sponsor":"Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd","participation":[{"nct":"NCT05768529","source":"https://clinicaltrials.gov/study/NCT05768529","fetchedAt":"2026-10-07T16:53:55.392Z","studySha256":"0a37a7b4aeebcde3cec071317059fc5a62a6159352e5ffc1f79f70f23c31405e","overallStatus":"RECRUITING","lastUpdatePosted":"2026-10-02","leadSponsor":"Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"70 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":100,"enrolmentType":"ESTIMATED","siteCount":3,"recruitingSiteCount":2,"countries":["China"]}],"started":"2023-03-28","startedType":"actual","enrolled":100,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05768529/","neighbours":{"cancer":[{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"company":[{"id":"unicar-therapy","kind":"company","name":"Unicar-Therapy","route":"/companies/unicar-therapy/"}]}}